Pyrazolyl conjugates of bombesin:: a new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety

被引:53
作者
Alves, Susana
Correia, Joao D. G.
Santos, Isabel
Veerendra, Bhadrasetty
Sieckman, Gary L.
Hoffman, Timothy J.
Rold, Tammy L.
Figueroa, Said Daibes
Retzloff, Lauren
McCrate, Joseph
Prasanphanich, Adam
Smith, Charles J.
机构
[1] Univ Missouri, Sch Med, Dept Radiol, Columbia, MO 65211 USA
[2] Univ Missouri, Univ Missouri Res Reactor Ctr, Columbia, MO 65211 USA
[3] Harry S Truman Mem Vet Hosp, Div Res, Columbia, MO 65201 USA
[4] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65211 USA
[5] Inst Tecnol & Nucl, Dept Quim, P-2686953 Sacavem, Portugal
[6] Univ Missouri, Sch Med, Radiopharmaceut Sci Inst, Columbia, MO 65211 USA
基金
美国国家卫生研究院;
关键词
technetium; carbonyl; bombesin; conjugates;
D O I
10.1016/j.nucmedbio.2006.03.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have described the synthesis of tridentate pyrazolyl ligand frameworks for coordination to the fac-[*M(CO)(3)](+) metal fragment (*M = Re-186/188 or Tc-99m). These ligands impart a degree of kinetic inertness on the metal center, warranting their study in biological systems. We herein report in vitro/in vivo radiolabeling investigations of a new series of pyrazolyl bombesin (BBN) conjugates radiolabeled via the Isolink kit. These new conjugates are based on the general structure [Tc-99m-pyrazolyl-X-BBN[7-14]NH2], where X=beta-alanine, serylserylserine or glycylglycylglycine. The pyrazolyl ligand is a tridentate ligand framework that coordinates the metal center through nitrogen donor atoms. The results of these investigations demonstrate the ability of these new conjugates to specifically target the gastrin-releasing peptide receptor subtype 2, which is overexpressed on human prostate PC-3 cancerous tissues. Therefore, these studies suggest the tridentate pyrazolyl ligand framework to be an ideal candidate for the design and development of low-valent Tc-99m-based diagnostic radiopharmaceuticals based on BBN or other targeting vectors. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:625 / 634
页数:10
相关论文
共 41 条
[11]  
Breeman WAP, 1999, INT J CANCER, V81, P658, DOI 10.1002/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO
[12]  
2-P
[13]  
Decristoforo C, 2002, Q J NUCL MED, V46, P195
[14]  
EGLI A, 1999, TECHNETIUM RHENIUM O, P507
[15]   99mTc-HYNIC-Bombesin (7-14)NH2:: Radiochemical evaluation with co-ligands EDDA (EDDA = ethylenediamine-N,N′-diacetic acid), tricine, and nicotinic acid [J].
Faintuch, BL ;
Santos, RLSR ;
Souza, ALFM ;
Hoffman, TJ ;
Greeley, M ;
Smith, CJ .
SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL CHEMISTRY, 2005, 35 (01) :43-51
[16]   Bombesin receptors in distinct tissue compartments of human pancreatic diseases [J].
Fleischmann, A ;
Läderach, U ;
Friess, H ;
Buechler, MW ;
Reubi, JC .
LABORATORY INVESTIGATION, 2000, 80 (12) :1807-1817
[17]   Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent [J].
Gali, H ;
Hoffman, TJ ;
Sieckman, GL ;
Owen, NK ;
Katti, KV ;
Volkert, WA .
BIOCONJUGATE CHEMISTRY, 2001, 12 (03) :354-363
[18]  
Giblin MF, 2005, IN VIVO, V19, P9
[19]  
Hoffman TJ, 2003, J NUCL MED, V44, P823
[20]   99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent [J].
Karra, SR ;
Schibli, R ;
Gali, H ;
Katti, KV ;
Hoffman, TJ ;
Higginbotham, C ;
Sieckman, GL ;
Volkert, WA .
BIOCONJUGATE CHEMISTRY, 1999, 10 (02) :254-260